Ivy Center at SNO
Meet Ivy Brain Tumor Center at SNO Annual Meeting
Ivy researchers to present encouraging results in multiple abstract presentations and posters
Leading neurosurgeons and neuroscientists from the Ivy Brain Tumor Center at Barrow Neurological Institute will present pacesetting research at the 2022 Society for Neuro-Oncology Annual Meeting in Tampa, Florida.
The Ivy Center’s multiple presentations represent the broad portfolio of pharmacodynamic and pharmacokinetic-driven clinical trials, combining industry-partnered drug development with the nation’s largest operative brain tumor volume. From first-in-human clinical trials to cutting-edge drug-device combinations, Ivy Center experts are leading the oncology field forward.
About SNO 2022
The theme of this year’s conference, “Examining Tumors and their Environment to Improve Patient Care,” aims to bridge the gap between neuro-oncology research and clinical practice. SNO gathers more than 2,600 researchers and clinical scientists from over 40 countries worldwide to share knowledge and insights on the future of neuro-oncology research and treatment.
What: 27th Annual Society for Neuro-Oncology (SNO) Meeting, the world’s largest neuro-oncology conference
Where: Tampa Convention Center, located in the heart of the Gulf Coast in Tampa Bay, Florida
When: November 16-20, 2022
Who: Leading, worldwide oncology experts including Ivy Brain Tumor Center clinicians, scientists and researchers
Hear from Ivy Experts
Expand the sections below for information on when and where to hear from our experts at SNO.
Featured Oral Presentations
For media inquiries, please contact: Jennifer Keeler
Discover clinical trials that offer patients access to cutting-edge treatments.Search Trials
Ivy Center Headquarters
The Ivy Brain Tumor Center is well underway on the construction of its new headquarters, the world’s largest translational research center dedicated solely to brain tumor drug development and treatment. The new building, located on the Dignity Health St. Joseph’s Hospital and Medical Center campus in Phoenix, Arizona, will be home to the Ivy Center’s scientists, investigators, clinicians and operational staff. In addition to laboratory space, the new building will house 14,000 square feet for trials infrastructure and 7,000 square feet for multidisciplinary clinical consultation, an MRI-guided ultrasound suite and a video teleconference auditorium.
Meet the Experts at SNO
Nader Sanai, MDChief Scientific Officer/Director Neurosurgical Oncologist
Kris Smith, MDNeurosurgical Oncologist
Shwetal Mehta, PhDChief Operating Officer, Deputy Director, Pre-Clinical Core Leader
Artak Tovmasyan, PhDPharmacokinetics Core Leader
An-Chi Tien, PhDPharmacodynamics Core Leader
Charuta Furey, MDNeurosurgery Resident
Wonsuk Yoo, PhDAssociate Professor of Biostatistics
Costanza Lo Cascio, PhDPostdoctoral Fellow
Sonam Patel, PhDPostdoctoral Fellow
Siddhi Desai, PhDPostdoctoral Fellow
Anilkumar Thaghalli Shivanna, PhDPostdoctoral Fellow
William KnightResearch Technician
Jacki Garcia, RN, CNRNNurse Navigator
Kristin HendricksonResearch Nurse
Jocelyn HarmonClinical Operations Manager
Amy HongData Management Specialist
Melinda LangdonDirector, Marketing and Communications
Michelle PalacinoMarketing Specialist
What It’s Like to Work Here
The Ivy Brain Tumor Center at Barrow Neurological Institute is singularly focused on finding a cure for brain cancer. We’re moving closer to that goal through cutting-edge research, unparalleled patient care and the excellence of our people. The Ivy Center has built a framework of tools and resources to provide team members opportunities for professional and personal growth, ultimately setting them up for success. We’re committed to a culture of innovation – it’s embedded in all we do and drives our mission forward.
Join Our Team
Be a part of a national movement to rapidly identify new drugs that will save the lives of those battling advanced brain tumors.
IVY CENTER NEWS
Ivy Brain Tumor Center Announces Initial Results of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma at the European Society for Medical Oncology (ESMO) 2022 Congress
Presented today at the ESMO Congress, Dr. Nader Sanai announced initial results in our Phase 0 clinical trial evaluating pamiparib in patients with #glioblastoma (NCT04614909). The interim analysis demonstrated that pamiparib is well-tolerated in glioblastoma patients.
Robust Glioblastoma Clinical Trials Program Offers Brain Cancer Patients New Treatment Options
Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care
The Ivy Brain Tumor Center announced its initiation of a ‘Liquid Biopsy’ program to obtain real-time insights into how a patient’s brain tumor is responding to experimental treatment.
Ivy Brain Tumor Center Announces Launch of Spanish-Language Website
The Ivy Brain Tumor Center has announced the launch of a new Spanish-language website, recognizing the importance of providing clinical trial information in multiple languages to patients and caregivers in the U.S. and around the world.
IN FINDING A CURE
If you represent a biotech or pharmaceutical company with investigational agents that would like to explore a partnership with the Ivy Brain Tumor Center please contact Dr. Nader Sanai.